All Blogs

Kx Advisors Names Sean Vander Linde Partner

Avatar photo
Sean Vander Linde

Kx Advisors Names Sean Vander Linde Managing Partner  

WASHINGTON, DC (April 4, 2022) – Kx Advisors is pleased to announce the promotion of Sean Vander Linde to Partner, effective today. Sean will help lead the firm’s healthcare strategy consulting services, based in Washington, DC.  

“Sean has been key in supporting Kx’s growth over his past 5 years with the firm.  He approaches his relationships with clients and colleagues with a level of thoughtfulness that is an example for all of us,” Bob Serrano, Managing Partner said.   

Sean joined Kx Advisors as a Principal in 2017. Since then, he has brought his deep industry expertise to strategy engagements for a range of pharmaceutical, digital health, and medical device clients. Prior to joining Kx, Sean held consultant roles at L.E.K. and PwC.  Sean earned his MBA from the Tuck School of Business at Dartmouth, and his Bachelor’s degree in Political Science from UNC Chapel Hill.  

“Sean is a valued colleague to Kx’s Partners, and a valuable mentor and leader to our junior team members. He is a trusted advisor for Pharma and MedTech clients and has made significant contributions to building these practices.” Jenna Riffell, Managing Parter, said. “We look forward to continuing our partnership with him and incorporate his vision for Kx’s growth and development.” 

Kx leadership is confident Sean will thrive in his new role. “Sean is a trusted partner to clients and colleagues and has played a pivotal role in the growth and success of our firm” Dan O’Neill, Managing Partner, said. “We congratulate him on this achievement and are excited to welcome him to the partner group.” 

About Kx Advisors    

For more than 40 years, Kx Advisors (operating as Kaiser Associates’ Healthcare Practice) has provided strategy consulting services to help healthcare executives achieve critical business growth goals. With a highly collaborative approach they have developed pragmatic solutions for leading pharmaceutical, biotechnology, medical device, health IT, and digital health clients, with data-driven insights to give those clients the tools to compete and win across the healthcare industry.